<DOC>
	<DOCNO>NCT00569894</DOCNO>
	<brief_summary>To assess safety FluMist vaccination</brief_summary>
	<brief_title>A Post Marking Study Evaluate Safety FluMist Children</brief_title>
	<detailed_description>- To assess safety FluMist vaccination Rates medically attend event FluMist recipient , include serious adverse event ( SAEs ) , anaphylaxis , urticaria , asthma , wheeze , pre-specified grouped diagnosis , rare event potentially relate wild-type influenza , compare rate multiple non-randomized control group . - To assess safety annual FluMist re-vaccination [ Rates MAEs subset child receive FluMist â‰¥2 consecutive year compare rate first-time vaccinee season . ] - To assess safety FluMist vaccination child previously vaccinate trivalent inactivate influenza vaccine ( TIV ) [ Rates MAEs subset child receive one prior TIV vaccination compare rate child receive prior TIV . ]</detailed_description>
	<criteria>Healthy Age : born within calendar quarter reference FluMist vaccinee . Children evidence medical condition put high risk complication influenza ( e.g. , chronic cardiovascular pulmonary disease ) exclude control group .</criteria>
	<gender>All</gender>
	<minimum_age>24 Months</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>